游泳诱发肺水肿:院前CPAP或呼气正压装置治疗评估
本研究在瑞典开放水域游泳赛事中对游泳诱发肺水肿(SIPE)患者进行前瞻性观察,评估院前无创正压通气(NPPV)的可行性与安全性。结果显示NPPV(CPAP或PEP装置)使91%患者现场出院,SpO2和患者报告的呼吸道症状改善,但听诊湿啰音和肺超声肺水肿未见显著减少。
要点
- NPPV是SIPE可行的院前治疗,91%患者现场出院。
- SpO2和患者报告症状可反映恢复,听诊和肺超声不敏感。
- 少数患者需气管插管或住院转移,需评估风险。
核心结论
- NPPV作为CPAP或PEP装置用于SIPE院前治疗可行且安全,绝大多数患者现场出院。
- SpO2和患者报告的呼吸道症状反映治疗后恢复,而肺部听诊或肺超声表现未反映恢复。
研究设计与样本
- 前瞻性观察性研究,2017至2019年在瑞典Vansbrosimningen开放水域游泳赛事进行。
- 纳入诊断为SIPE且SpO2≤95%或持续呼吸道症状的游泳者,共119例接受治疗。
主要发现
- 119例中94例接受CPAP,24例接受PEP装置,1例需气管插管。
- 108例(91%)经NPPV中位10至20分钟后出院,11例(9%)需医院转移。
- NPPV使SpO2中位数从91%升至97%(P < .0001),六项患者报告呼吸道症状改善(中位数字评分1-7降至0-1;P < .0001)。
- NPPV期间听诊湿啰音无显著减少(93% vs 87%;P = .508),肺超声肺水肿无显著减少(100% vs 97%;P = .500)。
关键数值与推荐
- 纳入标准:SIPE诊断且SpO2≤95%或持续呼吸道症状或两者兼具。
- 出院标准:SpO2 > 95%且临床恢复。
- NPPV给药方式:经面罩CPAP或经PEP装置给予呼气正压。
临床怎么用
- 对SIPE患者可考虑院前使用CPAP或PEP装置,以SpO2和患者报告症状评估疗效。
- 听诊和肺超声可能不适用于评估NPPV短期恢复,需结合其他指标。
局限性
- 本研究为观察性研究,未设对照组,无法确定NPPV相对于其他治疗的疗效。
- 样本来自单一赛事,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Swimming-induced pulmonary edema (SIPE) occasionally occurs during swimming in cold open water. Although optimal treatment for SIPE is unknown, non-invasive positive pressure ventilation (NPPV) is an option for prehospital treatment. RESEARCH QUESTION: Is NPPV a feasible and safe prehospital treatment for SIPE, and which outcome measures reflect recovery after treatment? STUDY DESIGN AND METHODS: A prospective observational study was conducted at Vansbrosimningen, Sweden's largest open water swimming event, from 2017 through 2019. Swimmers with a diagnosis of SIPE and with peripheral oxygen saturation (Spo2) of ≤ 95%, persistent respiratory symptoms, or both were eligible for the study. NPPV was administered on site as CPAP by facial mask or as positive expiratory pressure (PEP) by a PEP device. Discharge criteria were Spo2 of > 95% and clinical recovery. Four outcome measures were evaluated: Spo2, crackles on pulmonary auscultation, pulmonary edema on lung ultrasound (LUS), and patient-reported respiratory symptoms. RESULTS: Of 119 treated individuals, 94 received CPAP, 24 received treatment with a PEP device, and one required tracheal intubation. In total, 108 individuals (91%) were discharged after NPPV for a median of 10 to 20 min and 11 individuals (9%) required hospital transfer. NPPV resulted in increased Spo2 from a median of 91% to 97% (P < .0001) together with improvement of six patient-reported respiratory symptoms (median numerical rating scales, 1-7 to 0-1; P < .0001). No significant decrease in auscultation of crackles (93% vs 87%; P = .508) or pulmonary edema on LUS (100% vs 97%; P = .500) was seen during NPPV treatment. INTERPRETATION: NPPV administered as CPAP or via a PEP device proved feasible and safe as prehospital treatment for SIPE with a vast majority of patients discharged on site. Spo2 and patient-reported respiratory symptoms reflected recovery after treatment, whereas pulmonary auscultation or LUS findings did not.
引用
- Seiler C, Kristiansson L, Klingberg C, et al. Swimming-Induced Pulmonary Edema: Evaluation of Prehospital Treatment With CPAP or Positive Expiratory Pressure Device. Chest. 2022. PMID: 35288117. doi:10.1016/j.chest.2022.02.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。